CorMedix
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $31,209 | $11,456 | $806 | $0 |
Gross Profit | 30,034 | 10,769 | 296 | -818 |
EBITDA | 13,608 | -2,652 | -14,031 | -15,793 |
EBIT | 13,474 | -2,766 | -14,144 | -15,851 |
Net Income | 13,464 | -2,776 | -14,151 | -14,466 |
Net Change In Cash | 31,209 | 11,456 | 806 | 0 |
Free Cash Flow | -5,624 | -13,659 | -14,074 | -17,371 |
Cash | 40,650 | 35,286 | 28,540 | 35,256 |
Basic Shares | 61,508 | 58,825 | 57,620 | 57,503 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $43,472 | $0 | $65 | $190 |
Gross Profit | 40,281 | -205 | 61 | 41 |
EBITDA | -22,356,389 | -48,887 | -30,051 | -29,375 |
EBIT | -19,288 | -48,957 | -30,260 | -29,552 |
Net Income | -17,930 | -46,339 | -29,701 | -28,210 |
Net Change In Cash | 43,472 | 0 | 65 | 190 |
Cost of Revenue | 11,454 | |||
Free Cash Flow | -50,614,653 | -38,736 | -24,576 | -22,580 |
Cash | 40,650 | 43,642 | 43,374 | 53,551 |
Basic Shares | 58,871 | 50,902 | 40,274 | 37,666 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $0.22 |
2024-09-30 | -$0.05 |
2024-06-30 | -$0.25 |
2024-03-31 | -$0.25 |
